Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NVP-2002-R1
- Development stage
- Unknown
- Lead developer
- Navipharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NVP-2002-R1 appears to be a component of NVP-2002, which is being studied in clinical trials. It is designed to be co-administered with NVP-2002-R2. The drug is being evaluated for its pharmacokinetic characteristics and safety in healthy adult volunteers. The study is designed as a randomized, oral, single dose, 2×2 crossover trial. Developed by NVP Healthcare Co., Ltd.
Beyond the preview
Go deeper on NVP-2002-R1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NVP-2002-R1.